Chronic myelogenous leukemia (CML) in the chronic phase (CP), a clonal myeloproliferative disorder, is caused by the constitutively active BCR-ABL tyrosine kinase resulting from the translocation that produces the Philadelphia (Ph) chromosome. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.